Market Leadership Verantos is recognized as the global leader in high-validity real-world evidence, serving clients across pharmaceutical, biotech, and medical device companies that require precise, research-grade data for market access, regulatory submissions, and medical affairs.

Innovative Data Solutions With its advanced platform integrating heterogeneous data sources and employing AI technologies such as TensorFlow, Verantos provides scalable, high-validity RWE that can address complex evidence needs, ideal for organizations seeking to enhance clinical data accuracy and traceability.

Recent Strategic Partnerships Verantos’s collaborations with prominent pharma companies like Amgen and Curimeta demonstrate strong industry trust and open opportunities to offer tailored solutions for clinical research, patient stratification, and disease registries, particularly in areas like inflammatory bowel disease and severe asthma.

Growing Recognition Being listed among the fastest-growing North American tech companies and consistently recognized for its innovation signals expanding market demand, which presents opportunities for expanding into new therapeutic areas or geographic markets with proven scalable evidence-generation capabilities.

Expanding Data Assets The launch of specialized registries such as the IBD Pragmatic Registry showcases Verantos’s ability to deliver rich, disease-specific data, creating potential for targeted partnerships with healthcare providers and payers to develop patient-centric solutions and support value-based care initiatives.